// App-Quantinova.ai

LBP2 : Partial Aortic Occlusion with Neuroflo for Cerebral Perfusion Augmentation: Signals of Efficacy with Informative Study Endpoints

Researchers

Presenter

  • Ashfaq Shuaib

Principal Investigators

  • Hans-Christoph Diener

Medical Centers

  • University Hospital of Essen, Essen, Germany

  • David Geffen School of Medcn at UCLA, Los Angeles, CA

  • Univ. of Alberta, Edmonton, Alberta, Canada.

Locations

  • United States

  • Germany

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved